ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Xvivo Perfusion AB

Xvivo Perfusion AB (0RKL)

106,00
0,00
(0,00%)
Geschlossen 08 Juli 5:30PM

Xvivo Perfusion AB (0RKL) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
106,00
( - )
Gebot
106,00
Fragen
106,00
Volumen
119
Durchschnittliches Volumen (3 Mio.)
SEK 77.552
Finanzvolumen
-
0,00 Tagesbereich 0,00
106,00 52-Wochen-Bereich 106,00
Marktkapitalisierung
Unternehmenswert
8,634B
Handelsende
106,00
Handelsbeginn
-
Letzte Trade
41
@
284.2
(O)
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
834,53M
Nettogewinn (LTM)
73,86M
Ausgegebene Aktien
31.499.470
Streubesitz (%)
79,79%
Institutioneller Besitz (%)
43,41%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
119,51
Kurs-Umsatz-Verhältnis (KUV)
10,57
Gewinn pro Aktie (EPS)
2,34
Beta
1,46

Über Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers K... Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Mölndal, Sweden
Gegründet
1998
Xvivo Perfusion AB is listed in the sector of the Londoner Börse with ticker 0RKL. The last closing price for Xvivo Perfusion AB was SEK106,00. Over the last year, Xvivo Perfusion AB shares have traded in a share price range of SEK 106,00 to SEK 106,00.

Xvivo Perfusion AB currently has 31.499.470 shares in issue. The market capitalisation of Xvivo Perfusion AB is SEK3,34 billion. Xvivo Perfusion AB has a price to earnings ratio (PE ratio) of 119.51.

0RKL Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
26001061061068117106DE
52001061061068392106DE
156001061061066147106DE
260001061061064273106DE

0RKL - Frequently Asked Questions (FAQ)

What is the current Xvivo Perfusion AB share price?
The current share price of Xvivo Perfusion AB is SEK 106,00
How many Xvivo Perfusion AB shares are in issue?
Xvivo Perfusion AB has 31.499.470 shares in issue
What is the market cap of Xvivo Perfusion AB?
The market capitalisation of Xvivo Perfusion AB is SEK 3,34B
What is the 1 year trading range for Xvivo Perfusion AB share price?
Xvivo Perfusion AB has traded in the range of SEK 106,00 to SEK 106,00 during the past year
What is the PE ratio of Xvivo Perfusion AB?
The price to earnings ratio of Xvivo Perfusion AB is 119,51
What is the cash to sales ratio of Xvivo Perfusion AB?
The cash to sales ratio of Xvivo Perfusion AB is 10,57
What is the registered address of Xvivo Perfusion AB?
The registered address for Xvivo Perfusion AB is Gemenskapens gata 9, Mölndal, Västra Götaland County, 431 53
What is the Xvivo Perfusion AB website address?
The website address for Xvivo Perfusion AB is www.xvivogroup.com

0RKL Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen